• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A method to prevail false positive responses due to excess cations and viscous nature of Radiopharmaceuticals in Limulus Amebocyte Lysate Gel Clot test.一种在鲎试剂凝胶凝块试验中克服由于放射性药物中阳离子过量和粘性性质导致的假阳性反应的方法。
Asia Ocean J Nucl Med Biol. 2022 Spring;10(2):109-116. doi: 10.22038/AOJNMB.2021.59607.1416.
2
Limulus amebocyte lysate testing: adapting it for determination of bacterial endotoxin in 99mTc-labeled radiopharmaceuticals at a hospital radiopharmacy.鲎试剂检测:在医院放射性药房对其进行适应性调整,用于测定99mTc标记的放射性药物中的细菌内毒素。
J Nucl Med Technol. 2014 Dec;42(4):278-82. doi: 10.2967/jnmt.114.146779. Epub 2014 Nov 13.
3
A Validation Study of the Limulus Amebocyte Lysate Test as an End-Product Endotoxin Test for Polyvalent Horse Snake Antivenom.鲎试剂检测作为多价马蛇抗蛇毒血清终产品内毒素检测方法的验证研究
PDA J Pharm Sci Technol. 2019 Nov-Dec;73(6):562-571. doi: 10.5731/pdajpst.2018.009522. Epub 2019 Oct 15.
4
Case Report: Primary Hypothyroidism Associated With Lutetium 177-DOTATATE Therapy for Metastatic Paraganglioma.病例报告:177 镥-DOTATATE 治疗转移性副神经节瘤相关原发性甲状腺功能减退症。
Front Endocrinol (Lausanne). 2021 Jan 21;11:587065. doi: 10.3389/fendo.2020.587065. eCollection 2020.
5
The Bad Berka dose protocol: comparative results of dosimetry in peptide receptor radionuclide therapy using (177)Lu-DOTATATE, (177)Lu-DOTANOC, and (177)Lu-DOTATOC.巴德贝卡剂量方案:使用(177)镥-奥曲肽、(177)镥-多他奈和(177)镥-多他曲进行肽受体放射性核素治疗的剂量测定比较结果。
Recent Results Cancer Res. 2013;194:519-36. doi: 10.1007/978-3-642-27994-2_30.
6
Somatostatin receptor imaging in non-(131)I-avid metastatic differentiated thyroid carcinoma for determining the feasibility of peptide receptor radionuclide therapy with (177)Lu-DOTATATE: low fraction of patients suitable for peptide receptor radionuclide therapy and evidence of chromogranin A level-positive neuroendocrine differentiation.奥曲肽受体显像在非(131)I 摄取的转移性分化型甲状腺癌中评估(177)Lu-DOTATATE 肽受体放射性核素治疗的可行性:适合肽受体放射性核素治疗的患者比例较低,且存在嗜铬粒蛋白 A 水平阳性神经内分泌分化的证据。
Clin Nucl Med. 2014 Jun;39(6):505-10. doi: 10.1097/RLU.0000000000000429.
7
Comparison of [(177)Lu-DOTA(0),Tyr(3)]octreotate and [(177)Lu-DOTA(0),Tyr(3)]octreotide: which peptide is preferable for PRRT?[(177)Lu-DOTA(0),Tyr(3)]奥曲肽与[(177)Lu-DOTA(0),Tyr(3)]奥曲肽的比较:哪种肽更适合肽受体放射性核素治疗?
Eur J Nucl Med Mol Imaging. 2006 Nov;33(11):1346-51. doi: 10.1007/s00259-006-0172-9. Epub 2006 Jul 18.
8
Long-term outcome of indigenous Lu-DOTATATE PRRT in patients with Metastatic Advanced Neuroendocrine Tumours: a single institutional observation in a large tertiary care setting.在大型三级医疗机构中,观察单一机构内接受 Lu-DOTATATE PRRT 治疗的转移性晚期神经内分泌肿瘤患者的长期预后。
Br J Radiol. 2021 Jan 1;94(1117):20201041. doi: 10.1259/bjr.20201041. Epub 2020 Oct 29.
9
Initial clinical evaluation of indigenous Y-DOTATATE in sequential duo-PRRT approach (Lu-DOTATATE and Y-DOTATATE) in neuroendocrine tumors with large bulky disease: Observation on tolerability, Y-DOTATATE post- PRRT imaging characteristics (bremsstrahlung and PETCT) and early adverse effects.采用序贯双肽受体放射性核素治疗方法(镥[¹⁷⁷Lu] DOTATATE和钇[⁹⁰Y] DOTATATE)对伴有大块病灶的神经内分泌肿瘤进行国产钇[⁹⁰Y] DOTATATE的初始临床评估:耐受性观察、钇[⁹⁰Y] DOTATATE肽受体放射性核素治疗后的成像特征(轫致辐射和PETCT)及早期不良反应。
World J Nucl Med. 2020 Oct 2;20(1):73-81. doi: 10.4103/wjnm.WJNM_52_20. eCollection 2021 Jan-Mar.
10
High clinical and morphologic response using Y-DOTA-octreotate sequenced with Lu-DOTA-octreotate induction peptide receptor chemoradionuclide therapy (PRCRT) for bulky neuroendocrine tumours.使用钇-多胺-奥曲肽与镥-多胺-奥曲肽诱导肽受体化学放射性核素疗法(PRCRT)序贯治疗巨大神经内分泌肿瘤时具有较高的临床和形态学反应。
Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):476-489. doi: 10.1007/s00259-016-3527-x. Epub 2016 Sep 27.

本文引用的文献

1
Lutathera: The First FDA- and EMA-Approved Radiopharmaceutical for Peptide Receptor Radionuclide Therapy.镥[177Lu]奥曲肽:首个获美国食品药品监督管理局和欧洲药品管理局批准用于肽受体放射性核素治疗的放射性药物。
Pharmaceuticals (Basel). 2019 Jul 29;12(3):114. doi: 10.3390/ph12030114.
2
Lutetium-177 therapeutic radiopharmaceuticals: linking chemistry, radiochemistry, and practical applications.镥-177治疗性放射性药物:连接化学、放射化学与实际应用
Chem Rev. 2015 Apr 22;115(8):2934-74. doi: 10.1021/cr500171e. Epub 2015 Apr 13.
3
Limulus amebocyte lysate testing: adapting it for determination of bacterial endotoxin in 99mTc-labeled radiopharmaceuticals at a hospital radiopharmacy.鲎试剂检测:在医院放射性药房对其进行适应性调整,用于测定99mTc标记的放射性药物中的细菌内毒素。
J Nucl Med Technol. 2014 Dec;42(4):278-82. doi: 10.2967/jnmt.114.146779. Epub 2014 Nov 13.
4
How pH, Temperature, and Time of Incubation Affect False-Positive Responses and Uncertainty of the LAL Gel-Clot Test.pH值、温度和孵育时间如何影响鲎试剂凝胶法检测的假阳性反应和不确定性
PDA J Pharm Sci Technol. 2012 Nov-Dec;66(6):542-6. doi: 10.5731/pdajpst.2012.00887.
5
EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds.EANM 实践指南:经动脉内放射性化合物治疗肝癌和肝转移瘤
Eur J Nucl Med Mol Imaging. 2011 Jul;38(7):1393-406. doi: 10.1007/s00259-011-1812-2.
6
On the preparation of a therapeutic dose of 177Lu-labeled DOTA-TATE using indigenously produced 177Lu in medium flux reactor.关于使用中通量反应堆中本土生产的¹⁷⁷镥制备治疗剂量的¹⁷⁷镥标记的DOTA-TATE。
Appl Radiat Isot. 2007 Mar;65(3):301-8. doi: 10.1016/j.apradiso.2006.09.011. Epub 2006 Nov 15.
7
Roles of calcium ions in the activation and activity of the transglutaminase 3 enzyme.钙离子在转谷氨酰胺酶3的激活及活性中的作用。
J Biol Chem. 2003 Jun 27;278(26):23834-41. doi: 10.1074/jbc.M301162200. Epub 2003 Apr 4.
8
Three-dimensional structure of the human transglutaminase 3 enzyme: binding of calcium ions changes structure for activation.人转谷氨酰胺酶3的三维结构:钙离子结合改变结构以激活酶。
EMBO J. 2002 May 1;21(9):2055-67. doi: 10.1093/emboj/21.9.2055.
9
Separation of large and small granules from horseshoe crab (Tachypleus tridentatus) hemocytes and characterization of their components.从中国鲎血细胞中分离大小颗粒及其成分的表征。
J Biochem. 1993 Sep;114(3):307-16. doi: 10.1093/oxfordjournals.jbchem.a124173.
10
Limulus hemocyte transglutaminase. Its purification and characterization, and identification of the intracellular substrates.鲎血细胞转谷氨酰胺酶。其纯化与特性,以及细胞内底物的鉴定。
J Biol Chem. 1993 Jan 5;268(1):252-61.

一种在鲎试剂凝胶凝块试验中克服由于放射性药物中阳离子过量和粘性性质导致的假阳性反应的方法。

A method to prevail false positive responses due to excess cations and viscous nature of Radiopharmaceuticals in Limulus Amebocyte Lysate Gel Clot test.

作者信息

Mitra Arpit, Lad Sangita, Sahu Sudeep, Kulkarni Savita

机构信息

Medical Cyclotron Facility, Radiation Medicine Centre, Board of Radiation and Isotope Technology, Parel, Mumbai, India.

Radiation Medicine Centre, Bhabha Atomic Research Centre, Parel, Mumbai, India.

出版信息

Asia Ocean J Nucl Med Biol. 2022 Spring;10(2):109-116. doi: 10.22038/AOJNMB.2021.59607.1416.

DOI:10.22038/AOJNMB.2021.59607.1416
PMID:35800418
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9205850/
Abstract

OBJECTIVES

Bacterial endotoxin test (BET) for detection and quantification of endotoxin in radiopharmaceuticals (RPs), used for therapy or diagnosis, is prerequisite to administration in patients. Out of the two established methods used for this purpose (Kinetic Chromogenic Assay: KCM and Gel Clot Bacterial Endotoxin Test: GC-BET), GC-BET is recommended by pharmacopeias to evaluate the interferences exhibited during the assay due to presence of various ingredients in samples. In the present study, the influence of excess of cations in [Lu]Lu-DOTATATE, used for Peptide Receptor Radionuclide Therapy (PRRT), were studied and a protocol to negate the enhancement observed was developed. Additionally, a protocol for carrying out GC-BET for extremely viscous [I]I-Lipiodol was standardized.

METHODS

GC-BET was performed for [Lu]Lu-DOTATATE and [I]I-Lipiodol at maximum valid dilution (MVD), using LRW as a diluent. To negate the false positivity observed in case of [Lu]Lu-DOTATATE, various concentrations of calcium chloride (CaCl) were added and evaluated for the reversal of the interference observed initially. To prevail the difficulty in performing GC-BET for [I]I-Lipiodol various modification in the protocols like orbital vortexing at different rpm and time intervals were performed. KCM assays were also performed for studied RPs at MVD.

RESULTS

It was observed that at MVD, [Lu]Lu-DOTATATE exhibited false positivity in GC-BET. However, all the individual reagents used in labeling of [Lu]Lu-DOTATATE did not show any false positivity. Finally, performing the assay with an addition of 2mM CaCl (final concentration) nullified the false positivity. Further, intricacy in performing GC-BET for [I]I-Lipiodol due to its viscosity was resolved by orbital vortexing at 3000 rpm for 5 minutes.

CONCLUSIONS

Our study proved that false positivity was observed in GC-BET for [Lu]Lu-DOTATATE due to the presence excess M ions. Further, our study is the first of its kind which demonstrated methods for negating these false positive results by using modified protocol and hypothesizing the reason behind the enhancement. Additionally, ours is the first study which proved that a simple step of vortexing the viscous RPs like [I]I-Lipiodol can resolved the problems encountered during performing GC-BET due to viscosity of RPs.

摘要

目的

用于治疗或诊断的放射性药物(RP)中细菌内毒素检测(BET)及内毒素定量是其用于患者给药的前提条件。在用于此目的的两种既定方法(动态显色法:KCM和凝胶法细菌内毒素检测:GC - BET)中,药典推荐使用GC - BET来评估由于样品中存在各种成分而在检测过程中表现出的干扰。在本研究中,研究了用于肽受体放射性核素治疗(PRRT)的[¹⁷⁷Lu]Lu - DOTATATE中过量阳离子的影响,并制定了消除所观察到的增强作用的方案。此外,还对极粘稠的[¹³¹I]I - 碘油进行GC - BET的方案进行了标准化。

方法

以LRW为稀释剂,在最大有效稀释度(MVD)下对[¹⁷⁷Lu]Lu - DOTATATE和[¹³¹I]I - 碘油进行GC - BET。为消除[¹⁷⁷Lu]Lu - DOTATATE出现的假阳性,添加不同浓度的氯化钙(CaCl)并评估最初观察到的干扰的逆转情况。为克服对[¹³¹I]I - 碘油进行GC - BET的困难,对方案进行了各种修改,如在不同转速和时间间隔下进行轨道涡旋。还在MVD下对所研究的RP进行了KCM检测。

结果

观察到在MVD时,[¹⁷⁷Lu]Lu - DOTATATE在GC - BET中表现出假阳性。然而,用于标记[¹⁷⁷Lu]Lu - DOTATATE的所有单独试剂均未显示任何假阳性。最后,添加2mM CaCl(终浓度)进行检测消除了假阳性。此外,通过在3000 rpm下进行5分钟的轨道涡旋,解决了因[¹³¹I]I - 碘油粘度大而在进行GC - BET时的复杂性问题。

结论

我们的研究证明,由于存在过量的M离子,[¹⁷⁷Lu]Lu - DOTATATE在GC - BET中出现假阳性。此外,我们的研究是同类研究中的首例,展示了通过修改方案和推测增强背后的原因来消除这些假阳性结果的方法。另外,我们的研究首次证明,对像[¹³¹I]I - 碘油这样的粘性RP进行简单的涡旋步骤可以解决由于RP粘度在进行GC - BET时遇到的问题。